Oxford University Press (OUP) is delighted to announce the publication of the first issue of European Heart Journal - Cardiovascular Pharmacotherapy (EHJCVP), which it is publishing on behalf of the European Society for Cardiology (ESC) and the Working Group on Cardiovascular Pharmacotherapy.
Pharmacotherapy is an increasingly important area of cardiology given the high number of cardiac patients who are on medication of some kind. This new journal aims to publish the highest quality research, interpreting and integrating new scientific developments within the field of cardiovascular pharmacotherapy. The overarching goal of the journal is to improve the care of patients with cardiovascular disease with a specific focus on cardiovascular pharmacotherapy.
Professor Fausto Pinto, President of the ESC said: "The ESC is very proud to launch this new journal that will address a gap in cardiovascular publications today. Updated information on new treatment strategies is essential for today's practices and better patient management. I am certain that this new member of the ESC journal family will be very useful and well received by the cardiovascular community."
Helen Leipman, Senior Publisher at OUP said: "Oxford University Press is very proud to be involved in this new initiative of the ESC as publisher of their new journal. The field of clinical cardiovascular pharmacology is a burgeoning one but it is ever important to focus on improving prognosis for cardiovascular disease and we hope that we can go some way to achieving that with the new journal. Alongside European Heart Journal and Cardiovascular Research, EHJ-Cardiovascular Pharmacotherapy is an important addition to the ESC journal family and we look forward to working with Professor Agewall and his team to make it a great success."